PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsHiv-associated lipodystrophy syndrome
MeSH D039682 - hiv-associated lipodystrophy syndrome
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D015658:Hiv infections
44 Companies
40 Drugs
$
Success rate
D008060:Lipodystrophy
2 Companies
1 Drug
$
Success rate
D039682: 
Hiv-associated lipodystrophy syndrome
1 Company
1 Drug
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TheratechnologiesTesamorelin Egrifta SV  2010-11-10   
Clinical Trials
Historical Success Rate
Phase 1
40%
2/5
Phase 2
25%
1/4
Phase 3
50%
1/2
Approved: 1Overall Success rate: 5%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Theratechnologies
Tesamorelin
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use